Clinical Trial Update: A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 study of GDC-0084 in patients with progressive or recurrent high-grade glioma has completed. Indications studied include glioblastoma and glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• GDC-0084

Snippet

Sponsor: Genentech, Inc. | Conditions: Glioblastoma, Glioma | Phase 1 | Status: COMPLETED